Form 4 for PG Procter & Gamble
Accepted 2022-08-18 00:00:00 ET · period of report 2022-08-16 · accession 0001127602-22-021279 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-08-18 | 2022-08-17 | PG | Davis Jennifer L. | CEO - Health Care | S - Sale | $149.33 | -7,621 | 32.9K | -19% | -$1.14M |
| D | 2022-08-18 | 2022-08-16 | PG | Davis Jennifer L. | CEO - Health Care | A - Grant | $0.00 | +19.0K | 40.5K | +88% | $0 |
| D | 2022-08-18 | 2022-08-15 | PG | Davis Jennifer L. | CEO - Health Care | A - Grant | $0.00 | +8.62 | 16.85 | +105% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-17 | S | D | 7,621 | $149.33 | 32,894.79 | D | — | — | (F3) Shares sold to cover taxes on Stock Award. |
| 2 | Common | Common Stock | 2022-08-16 | A | A | 19,021 | $0.00 | 40,515.79 | D | — | — | (F1) Stock award pursuant to issuer's 2019 Stock and Incentive Compensation Plan. (F2) Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. |
| 3 | Derivative | Restricted Stock Units | 2022-08-15 | A | A | 8.62 | $0.00 | 16.85 | D | — · — to — | 8.62 Common Stock | (F4) Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. (F5) These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. |